Bill Cassidy actually said...
We want the orphan drug benefit, but we also don't want this kind of arbitrage where it then introduces a higher price than it should be for something else.
Context
Cassidy emphasizes the need to balance orphan drug benefits with pricing issues.
03/22/2021